Dianthus Therapeutics, Inc.: Dianthus Therapeutics Announces Initiation of Phase 3 Emerge Trial of Claseprubart in Generalized Myasthenia Gravis

EMERGE is a global, randomized, multicenter, placebo-controlled Phase 3 trial that will evaluate claseprubart 300mg/2mL S.C. dosed Q2W and Q4W vs. placebo, with top-line results anticipated in 2H'28 ...
TMCnet

Dianthus Therapeutics Announces Initiation of Phase 3 Emerge Trial of Claseprubart in Generalized Myasthenia Gravis

Advancing a neuromuscular franchise with claseprubart, a highly potent investigational classical pathway inhibitor, across generalized Myasthenia Gravis (gMG), Multifocal Motor Neuropathy (MMN) and ...
MarketersMEDIA Newsroom

Creative Biolabs Empowers Researchers to Overcome Hurdles in Complement Drug Development

Creative Biolabs has expanded its complement testing capabilities to help researchers overcome challenges in complement drug development through comprehensive complement activity assays, CH50 ...
USA Today

Music Pathway Choir Presents Musical Theater Concert at The DiMenna Center for Classical Music

Founder Alicia Liu Continues to Build a Performance-Oriented Adult Music Community in New York. New York, NY, United States, June 18, 2026 — Music Pathway Choir presented a musical-theater-themed ...
Frontiers

Serum complement system activation in normal healing and atrophic non-union of human long bone fractures

The complement system has an important role in physiological bone healing, as studied mainly in animal models and local bone tissues. However, the role of the complement system in human fractures, ...
The New York Times

6 Podcasts About Classical Music

Performances in N.Y.C. Advertisement Supported by These shows demystify a genre unfairly perceived as archaic and stuffy with expert analysis, musical selections and pure fun. By Emma Dibdin Classical ...
Everyday Health

Understanding the ‘C3’ in C3G: Your Guide to Monitoring Complement Activity

C3G and IC-MPGN can be difficult to diagnose because they are so rare and their symptoms are vague and nonspecific. A kidney biopsy is considered the gold standard and usually needed to confirm the ...
STAT

FDA unveils rules for bespoke gene therapies, predicting flood of rare disease applications

Jason is a general assignment reporter, with particular focus on genetic medicine and rare disease. Confidential tips can be sent on Signal at JasonMast.77. Lizzy leads STAT’s coverage of the FDA. Her ...
Medical Xpress

Study splits schizophrenia genetic risk into two pathways, one shared with bipolar disorder

A new study by researchers at King's College London has split schizophrenia risk into two genetically distinct pathways. One is characterized by a shared genetic risk with bipolar disorder and ...
The New York Times

Stop Mutilating Classical Music to Sell It to Kids

Mr. Shinners is a pianist and harpsichordist and hosts the podcast “W.T.F. Bach.” See more of our coverage in your search results.Encuentra más de nuestra cobertura en los resultados de búsqueda. Add ...
FierceBiotech

UPDATED: Prasad, Makary unveil new FDA path for accelerating custom gene editing therapies

Health officials including FDA Commissioner Marty Makary, M.D., have openly voiced support for the development of novel cell and gene therapies. (Brendan Smialowski/AFP via Getty Images) In a highly ...